JP3495000006
JP3495000006
SUMITOMO PHARMA CO LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 453.294.000.000 | 398.832.000.000 | 13.7% |
| Cost of Revenue | 196.401.000.000 | 153.437.000.000 | 28.0% |
| Gross Profit | 256.893.000.000 | 245.395.000.000 | 4.7% |
| 151.840.000.000 | 215.686.000.000 | 29.6% | |
| Operating Income | 105.053.000.000 | 29.709.000.000 | 253.6% |
| Pretax Income | 100.344.000.000 | 17.611.000.000 | 469.8% |
| Net Income Common Stockholders | 106.865.000.000 | 23.634.000.000 | 352.2% |
| -- | -- | -- | |
| -- | -- | -- |